U.S. Market for Diabetes Monitoring, Treatment and Drug Delivery

The U.S. market for diabetes diagnosis, treatment and drug delivery is expected to exceed $17.87 billion by 2018.

The market segments covered in this report include:

• traditional blood glucose meters,
• continuous glucose monitoring systems,
• blood glucose test strips,
• lancets and lancing devices,
• insulin,
• insulin syringes,
• insulin pens and
• insulin pumps

Market growth is expected to be fueled by an increasing number of diabetics and improved education regarding the importance of blood glucose management. Factors such as high obesity rates, poor diet and lack of exercise will contribute to the growing type 2 diabetic population.

Market growth for diabetes diagnosis, treatment and drug delivery will be led by double-digit growth in the continuous glucose monitor, insulin pen and insulin pump segments.

Within the diabetes diagnosis, treatment and drug deliver market, companies such as Novo Nordisk, Sanofi, Eli Lilly and Lifescan lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.

Table of Contents

EXECUTIVE SUMMARY
1.1 U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY MARKET
1.2 GROWTH TRENDS BY SEGMENT
1.3 BLOOD GLUCOSE MONITORING MARKET
1.4 INSULIN MARKET
1.5 INSULIN SYRINGE MARKET
1.6 INSULIN PEN MARKET
1.7 INSULIN PUMP MARKET
1.8 COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY
2.1 RESEARCH SCOPE
2.2 IDATA’S 9-STEP METHODOLOGY
Step 1: Project Initiation & Team Selection
Step 2: Prepare Data Systems and Perform Secondary Research
Step 3: Preparation for Interviews & Questionnaire Design
Step 4: Performing Primary Research
Step 5: Research Analysis: Establishing Baseline Estimates
Step 6: Market Forecast and Analysis
Step 7: Identify Strategic Opportunities
Step 8: Final Review and Market Release
Step 9: Customer Feedback and Market Monitoring

U.S. DIABETES DIAGNOSIS, TREATEMENT AND DRUG DELIVERY MARKET
3.1 INTRODUCTION
3.1.1 Types of Diabetes
3.1.1.1 Type 1 Diabetes
3.1.1.2 Type 2 Diabetes
3.1.1.3 Gestational Diabetes
3.1.1.4 Prediabetes
3.1.2 Diabetes Complications
3.1.3 Risk Factors Associated with Type I and Type 2 Diabetes
3.1.4 Signs and Symptoms
3.1.5 Diabetes Monitoring
3.1.5.1 Initial Diagnosis
3.1.5.2 Blood Glucose Monitoring Systems
3.1.5.3 Urinary Glucose Monitoring
3.1.5.4 Noninvasive and Minimally Invasive Monitoring Devices
3.1.6 Treatment
3.1.6.1 Lifestyle Measures
3.1.6.2 Insulin
3.1.6.3 Oral Antidiabetic Drugs
3.1.6.4 Injectable Antidiabetic Drugs
3.1.7 Drug Delivery Systems
3.1.7.1 Insulin Syringes
3.1.7.2 Insulin Pens
3.1.7.3 Insulin Pumps
3.1.7.4 Inhaled Insulin
3.2 MARKET OVERVIEW
3.3 TREND ANALYSIS BY MARKET SEGMENT
3.4 MARKET DRIVERS AND LIMITERS
3.4.1 Market Drivers
3.4.2 Market Limiters
3.5 COMPETITIVE ANALYSIS
3.5.1 Market Concentration
3.6 MERGERS AND ACQUISITIONS

TRADITIONAL BLOOD GLUCOSE METER MARKET
4.1 INTRODUCTION
4.2 MARKET OVERVIEW
4.3 MARKET ANALYSIS AND FORECAST
4.3.1 Professional Blood Glucose Meter Market
4.3.2 Personal Blood Glucose Meter Market
4.4 MARKET DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE ANALYSIS

CONTINUOUS GLUCOSE MONITORING MARKET
5.1 INTRODUCTION
5.2 MARKET OVERVIEW
5.2.1 Total Continuous Glucose Monitoring Market
5.2.2 Emerging Markets: Intravascular Continuous Glucose Monitoring
5.3 MARKET ANALYSIS AND FORECAST
5.3.1 Total CGM Market
5.4 MARKET DRIVERS AND LIMITERS
5.4.1 Market Drivers
5.4.2 Market Limiters
5.5 COMPETITIVE ANALYSIS

BLOOD GLUCOSE TEST STRIP MARKET
6.1 INTRODUCTION
6.2 MARKET OVERVIEW
6.3 MARKET ANALYSIS AND FORECAST
6.3.1 Professional Blood Glucose Test Strip Market
6.3.2 Personal Blood Glucose Test Strip Market
6.4 MARKET DRIVERS AND LIMITERS
6.4.1 Market Drivers
6.4.2 Market Limiters
6.5 COMPETITIVE ANALYSIS

LANCET AND LANCING DEVICE MARKET
7.1 INTRODUCTION
7.2 MARKET OVERVIEW
7.3 MARKET ANALYSIS AND FORECAST
7.3.1 Professional Lancet and Lancing Device Market
7.3.2 Personal Lancet and Lancing Device Market
7.4 MARKET DRIVERS AND LIMITERS
7.4.1 Market Drivers
7.4.2 Market Limiters
7.5 COMPETITIVE ANALYSIS

INSULIN MARKET
8.1 INTRODUCTION
8.1.1 Insulin Types
8.2 MARKET OVERVIEW
8.3 MARKET ANALYSIS AND FORECAST
8.4 MARKET DRIVERS AND LIMITERS
8.4.1 Market Drivers
8.4.2 Market Limiters
8.5 COMPETITIVE ANALYSIS

INSULIN SYRINGE MARKET
9.1 INTRODUCTION
9.2 MARKET OVERVIEW
9.3 MARKET ANALYSIS AND FORECAST
9.3.1 Professional Insulin Syringe Market
9.3.2 Personal Insulin Syringe Market
9.4 MARKET DRIVERS AND LIMITERS
9.4.1 Market Drivers
9.4.2 Market Limiters
9.5 COMPETITIVE ANALYSIS

INSULIN PEN MARKET
10.1 INTRODUCTION
10.2 MARKET ANALYSIS AND FORECAST
10.3 MARKET DRIVERS AND LIMITERS
10.3.1 Market Drivers
10.3.2 Market Limiters
10.4 COMPETITIVE ANALYSIS

INSULIN PUMP MARKET
11.1 INTRODUCTION
11.2 MARKET OVERVIEW
11.3 MARKET ANALYSIS AND FORECAST
11.3.1 Total Traditional Insulin Pump Market
11.3.1.1 Traditional Pump Market
11.3.1.2 Infusion Set Market
11.3.2 Total Patch Pump Market
11.3.2.1 Patch Pump Controller Market
11.3.2.2 Insulin Pod Market
11.3.3 Simple Pump Market
11.4 MARKET DRIVERS AND LIMITERS
11.4.1 Market Drivers
11.4.2 Market Limiters
11.5 COMPETITIVE ANALYSIS
11.5.1.1 Emerging Competitors

APPENDIX 1: EMERGING MARKETS & ALTERNATIVE THERAPIES
12.1 ARTIFICIAL PANCREAS
12.1.1 Mechanical Artificial Pancreas
12.1.2 Bio-Artificial Pancreas
12.2 NEEDLESS INJECTORS

ABBREVIATIONS